LabCorp reports revenue dip in Q2

By staff writers

July 28, 2020 -- The COVID-19 pandemic resulted in a 3.9% drop in revenue for LabCorp in its second quarter.

For the period (end-June 30), LabCorp had $2.8 billion in revenue, down from $2.9 billion in the same period last year, a decline that was partially offset by COVID-19 testing sales, LabCorp said.LabCorp had second-quarter earnings of $231.6 million, up from $190.4 million in the same period a year ago.

As part of its earnings report, the company noted it has processed more than 8.5 million molecular COVID-19 tests to date, increased capacity to approximately 8.5 million molecular tests per day, and delivered results on average in two to three days, with faster results for hospitalized patients.

The company was granted an emergency use authorization this week from the U.S. Food and Drug Administration for its matrix pooled testing, which allows testing of up to five different samples at the same time.

LabCorp launches smart laboratory test reports
LabCorp has launched Insight Analytics, intelligent reports that combine national laboratory test values with patient demographics.
Humana offers LabCorp at-home COVID-19 test, partners with Walmart, Quest
Health insurer Humana is offering LabCorp's at-home COVID-19 test kit in a pilot home testing program for members. It has also formed a new collaboration...
LabCorp neutralizing antibody test could help screen recovered COVID-19 patients
LabCorp has launched a new neutralizing antibody test that it says will be useful in the development of vaccines and in screening the plasma of recovered...
LabCorp gives employers a hand with screening staff for coronavirus
LabCorp is launching return-to-work services to help employers screen their staff for COVID-19, including antibody blood tests.
LabCorp expands access to at-home coronavirus testing
LabCorp is now opening up its at-home coronavirus molecular diagnostic testing to consumers, having initially offered it to healthcare workers and first...

Copyright © 2020

Last Updated ls 7/28/2020 2:41:04 PM

Register below for our weekly Letter from the Editor to receive the latest Clinical Lab news and insights.